Print
| DAY 1 | Auditorium | DAY 1 |
| DAY 1 | Auditorium | DAY 1 |
| 9:00 | 9:00: | |
| 9:05: | 9:05: | |
| 9:10: | 9:10: | |
| 9:15: | 9:15: | |
| 9:20: | 9:20: | |
| 9:25: | 9:25: | |
| 9:30: | Registration & Refreshments | 9:30: |
| 9:35: | 9:35: | |
| 9:40: | 9:40: | |
| 9:45: | 9:45: | |
| 9:50: | 9:50: | |
| 9:55: | 9:55: | |
| 10:00 | Welcome and Introductions Chairs: Nick Clare, Synthego Scott Cribbes, Nexcelom Bioscience from Perkin Elmer |
10:00 |
| 10:05 | 10:05 | |
| 10:10 | Challenges and opportunities with clinical grade pluripotent stem cells in cell and gene therapy 10:10 (30 mins) Rowan Flynn, RoslinCT Ewa Guzniczak, RoslinCT SNBTS Tissues, Cells and Advanced Therapeutics – The route from Research to Translation and Manufacturing 10:40 (30 mins) Alasdair Fraser, NHS National Services Scotland Accurate 3D models for cancer drug testing 11:25 (30 mins) Ishani Malhotra, Carcinotech Poised neural progenitors for the neuroscience community 11:55 (30 mins) Tilo Kunath, University of Edinburgh |
10:10 |
| 10:15 | 10:15 | |
| 10:20 | 10:20 | |
| 10:25 | 10:25 | |
| 10:30 | 10:30 | |
| 10:35 | 10:35 | |
| 10:40 | 10:40 | |
| 10:45 | 10:45 | |
| 10:50 | 10:50 | |
| 10:55 | 10:55 | |
| 11:00 | 11:00 | |
| 11:05 | 11:05 | |
| 11:10 | 11:10 | |
| 11:15 | 11:15 | |
| 11:20 | 11:20 | |
| 11:25 | 11:25 | |
| 11:30 | 11:30 | |
| 11:35 | 11:35 | |
| 11:40 | 11:40 | |
| 11:45 | 11:45 | |
| 11:50 | 11:50 | |
| 11:55 | 11:55 | |
| 12:00 | 12:00 | |
| 12:05 | 12:05 | |
| 12:10 | 12:10 | |
| 12:15 | 12:15 | |
| 12:20 | 12:20 | |
| 12:25 | Refreshments | 12:25 |
| 12:30 | 12:30 | |
| 12:35 | 12:35 | |
| 12:40 | 12:40 | |
| 12:45 | 12:45 | |
| 12:50 | 12:50 | |
| 12:55 | 12:55 | |
| 1:00 | 1:00: | |
| 1:05: | 1:05: | |
| 1:10: | 1:10: | |
| 1:15: | 1:15: | |
| 1:20: | 1:20: | |
| 1:25: | Considerations for biosafety testing of cell and gene therapies 13:25 (30 mins) Richard Adair, SGS Vitrology Limited Macrophage Therapy for Inflammatory Disease 13:55 (30 mins) John Campbell, NHS National Services Scotland Setting new quality standards in iPSC manufacturing 14:25 (15 mins) Mhairi Rodgers — Axol Bioscience Ltd. Scalable, renewable and engineerable developmental cell secretomes for host defence, repair and regeneration 14:40 (30 mins) Paul de Sousa , University of Edinburgh |
1:25: |
| 1:30: | 1:30: | |
| 1:35: | 1:35: | |
| 1:40: | 1:40: | |
| 1:45: | 1:45: | |
| 1:50: | 1:50: | |
| 1:55: | 1:55: | |
| 2:00 | 2:00: | |
| 2:05: | 2:05: | |
| 2:10: | 2:10: | |
| 2:15: | 2:15: | |
| 2:20: | 2:20: | |
| 2:25: | 2:25: | |
| 2:30: | 2:30: | |
| 2:35: | 2:35: | |
| 2:40: | 2:40: | |
| 2:45: | 2:45: | |
| 2:50: | 2:50: | |
| 2:55: | 2:55: | |
| 3:00 | 3:00: | |
| 3:05: | 3:05: | |
| 3:10: | 3:10: | |
| 3:15: | 3:15: | |
| 3:20: | 3:20: | |
| 3:25: | 3:25: | |
| 3:30: | 3:30: | |
| 3:35: | 3:35: | |
| 3:40: | 3:40: | |
| 3:45: | 3:45: | |
| 3:50: | 3:50: | |
| 3:55: | 3:55: | |
| 4:00 | 4:00: | |
| 4:05: | 4:05: | |
| 4:10: | 4:10: | |
| 4:15: | 4:15: | |
| 4:20: | 4:20: | |
| 4:25: | 4:25: | |
| 4:30: | 4:30: | |
| 4:35: | 4:35: | |
| 4:40: | 4:40: | |
| 4:45: | 4:45: | |
| 4:50: | 4:50: | |
| 4:55: | 4:55: | |
| 5:00 | 5:00: | |
| 5:05: | 5:05: | |
| 5:10: | 5:10: | |
| 5:15: | 5:15: | |
| 5:20: | 5:20: | |
| 5:25: | 5:25: | |
| 5:30: | 5:30: | |
| 5:35: | 5:35: | |
| 5:40: | 5:40: | |
| 5:45: | 5:45: | |
| 5:50: | 5:50: | |
| 5:55: | 5:55: | |
| 6:00 | 6:00: |
